NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 254 filers reported holding NOVAVAX INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,154 | -2.3% | 23,502 | +0.3% | 0.00% | – |
| Q2 2023 | $174,091 | +25.6% | 23,431 | +17.1% | 0.00% | – |
| Q1 2023 | $138,662 | -38.3% | 20,009 | -8.5% | 0.00% | – |
| Q4 2022 | $224,772 | -31.1% | 21,865 | +22.0% | 0.00% | – |
| Q3 2022 | $326,000 | -67.2% | 17,923 | -7.2% | 0.00% | -100.0% |
| Q2 2022 | $994,000 | -24.1% | 19,319 | +8.6% | 0.00% | 0.0% |
| Q1 2022 | $1,310,000 | -51.4% | 17,789 | -5.5% | 0.00% | -50.0% |
| Q4 2021 | $2,694,000 | -72.1% | 18,834 | -59.6% | 0.00% | -66.7% |
| Q3 2021 | $9,671,000 | +85.0% | 46,649 | +89.5% | 0.01% | +100.0% |
| Q2 2021 | $5,227,000 | +31.8% | 24,616 | +12.6% | 0.00% | 0.0% |
| Q1 2021 | $3,965,000 | +80.3% | 21,871 | +10.9% | 0.00% | +50.0% |
| Q4 2020 | $2,199,000 | +33.5% | 19,723 | +29.8% | 0.00% | +100.0% |
| Q3 2020 | $1,647,000 | +16.1% | 15,196 | -10.8% | 0.00% | 0.0% |
| Q2 2020 | $1,419,000 | – | 17,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |